ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,954.50
1.59%
US Tech 100
20,332.80
1.61%
Dow Jones
43,840.91
1.39%
Brent Oil
73.045
0.00%
Bitcoin
93,967.85
9.22%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. USA
  5. AMEX

  6. Vanguard Intermediate Term Bond (BIV) Quote

Vanguard Intermediate Term Bond

Vanguard Intermediate Term Bond (BIV)

AMEX
76.59
0.33
(0.43%)
Closed March 02 4:00PM
Delayed by 15 minutes
76.60
0.01
(0.01%)
After Hours: 7:59PM
Delayed by 15 minutes
Advanced chart

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
76.59
Bid
-
Ask
-
Volume
1,493,711
76.3241 Day's Range 76.61
72.951 52 Week Range 78.89
Market Cap
16.8B
Previous Close
76.26
Open
76.43
Last Trade
3998
@
76.59
Last Trade Time
Financial Volume
$ 114,217,765
VWAP
76.4658
Average Volume (3m)
1,376,243
Shares Outstanding
219,354,000
Dividend Yield
-
PE Ratio
7.98
Earnings Per Share (EPS)
9.6
Revenue
1.15B
Net Profit
2.11B

About Vanguard Intermediate Term Bond

The investment seeks the performance of the Bloomberg Barclays U. Bloomberg Barclays U.S. 5-10 Year Government/Credit Float Adjusted Index includes all medium and larger issues of U.S. government, investment-grade corporate and investment-grade international dollar-denominated bonds that have maturi... The investment seeks the performance of the Bloomberg Barclays U. Bloomberg Barclays U.S. 5-10 Year Government/Credit Float Adjusted Index includes all medium and larger issues of U.S. government, investment-grade corporate and investment-grade international dollar-denominated bonds that have maturities between 5 and 10 years and are publicly issued. All of its investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Website
www.vanguard.com
Headquarters
Valley Forge, Pennsylvania, USA
Founded
-
Vanguard Intermediate Term Bond is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker BIV. The last closing price for Vanguard Intermediate Term was $76.26. Over the last year, Vanguard Intermediate Term shares have traded in a share price range of $ 72.951 to $ 78.89.

Vanguard Intermediate Term currently has 219,354,000 shares outstanding. The market capitalization of Vanguard Intermediate Term is $16.73 billion. Vanguard Intermediate Term has a price to earnings ratio (PE ratio) of 7.98.

BIV Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.241.6456536164675.3576.675.32125262675.99331066SP
41.271.6861391396775.3276.674.46128411675.33414887SP
120076.5976.6473.72137624375.04639975SP
26-1.29-1.65639445377.8878.8973.72128596476.00538903SP
521.872.5026766595374.7278.8972.951113869175.63506621SP
156-8.01-9.4680851063884.685.6570.425117507175.86375825SP
260-13.99-15.444910576390.589570.425117729881.71984945SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STAKSTAK Inc
$ 3.97
(156.13%)
174.23k
ORGOOrganogenesis Holdings Inc
$ 6.21
(102.28%)
59M
TRNRInteractive Strength Inc
$ 2.57
(67.97%)
193.57M
PMAXPowell Max Ltd
$ 0.511
(43.54%)
137.18M
ARBBARB IOT Group Ltd
$ 0.6635
(38.23%)
59.08M
NVNINVNI Group Ltd
$ 0.99
(-50.50%)
72.79M
SPGCSacks Parente Golf Inc
$ 0.2085
(-48.65%)
58.21M
ADGMAdagio Medical Holdings Inc
$ 0.8081
(-47.53%)
756.76k
PRAXPraxis Precision Medicines Inc
$ 38.60
(-40.64%)
3.2M
SAGSAG Holdings Ltd
$ 1.19
(-38.97%)
789.86k
NVDANVIDIA Corporation
$ 124.92
(3.97%)
379.97M
TRNRInteractive Strength Inc
$ 2.57
(67.97%)
192.48M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 13.44
(7.78%)
153.64M
PMAXPowell Max Ltd
$ 0.511
(43.54%)
136.35M
LCIDLucid Group Inc
$ 2.22
(-0.45%)
134.28M

BIV Financials

Financials

Discussion

View Full Feed
jammy32 jammy32 32 seconds ago
The stock is dropping every day and nasrat is losing millions. He should sell the company now.
ELTP
BDEZ BDEZ 43 seconds ago
Kirk said on Friday he thinks most Epstein files have been destroyed
dmb2 dmb2 53 seconds ago
All supporting data can be submitted to an RA as further evidence, it will be appropriately weighted by the RA. The problem with informally continuing to collect OS data is that it is important to follow all the patients in the study, as much as possible, to have the most usable info. I would think
NWBO PIII
nadodude nadodude 57 seconds ago
So many values, kinda confusing. I'm not alone here and would like an update from any who wish to share as to the possible returns per old "P" & "U" shares. Lucky to be alive at this point. Thanks in advance.
COOP
3Angels120702 3Angels120702 1 minute ago
Or the following Tuesday or the following. You part of the monthly paid promo?
NBRI
SkyLimit2022 SkyLimit2022 2 minutes ago
LC,

Good point 😶

https://investorshub.advfn.com/uimage/uploads/2024/11/6/rkwdpgiphy.gif

Yes, there are “free and promising trials” here is the U.S. that are supported by continuing peer-reviewed grants awarded by the U.S. NIH and the U.S. DoD.
NWBO
BDEZ BDEZ 2 minutes ago
Yeah wondering how many still run on Nuclear...
blackhawks blackhawks 2 minutes ago
For those who missed it. And yes, that is Mike Myers as Musk.

[yt]CUpOMSJ1MdU[/yt]
theswordman theswordman 3 minutes ago
So do you know--since FDA already granted "fast track" designation for mTNBC in MAY 2019--and it has been 6 years; exactly what is benefit of another mouse study ?? Here is link-- https://www.onclive.com/view/fda-grants-fast-track-designation-to-leronlimab-for-metastatic-tnbc

So do t
CYDY
blackhawks blackhawks 3 minutes ago
For those who missed it. And yes, that is Mike Myers as Musk.

[yt]CUpOMSJ1MdU[/yt]
joe botts joe botts 3 minutes ago
Never, it's REVOKED.
carvajal carvajal 4 minutes ago
What was the market cap when it ran to 7 bucks ?
HMBL
blackhawks blackhawks 4 minutes ago
For those who missed it. And yes, that is Mike Myers as Musk.

[yt]CUpOMSJ1MdU[/yt]
BakedLangostino BakedLangostino 4 minutes ago
Operating costs will be way above $2 billion.

Figure Anavex gets .25 per pill sold, excluding its operating costs. I’d expect Anavex to net around .10-.20 after all costs are tallied. Remember that Anavex is going to also spend hundreds of millions or more trying to advance A371, Ret
PDD
Demolition Man Demolition Man 4 minutes ago
Thanks for posting! What a great article about NioCorp. Just need EXIM or one of the 2,781 Billionaires in the World to throw us a bone.
NB
Myth Myth 4 minutes ago
Thanks Cap. I heard a couple of songs off that album years ago but never kniw Warren played on it and produced.

He even let him do Soul Shine...lol..

https://www.youtube.com/watch?v=SlzJTwnY2qA
nyt nyt 4 minutes ago
Apparently, it's not part of grammar, but only works in conjunction with.
VPLM
GolfnutBoston GolfnutBoston 4 minutes ago
Should do wellness check on JusDePomme, he's been quiet, although not complaining :-) 
AFFU
EliSmith EliSmith 5 minutes ago
Bitcoin is the easiest game to win on. the entire planet.
INTV
PennyMillions852 PennyMillions852 6 minutes ago
Penny break this week! 🚨🚨
IGPK
Runners123 Runners123 6 minutes ago
Trump bloats crypto hopes as suckers jump in, he may not have the authority huh?
blackhawks blackhawks 6 minutes ago
For those who missed it.

[yt]CUpOMSJ1MdU[/yt]
mascale mascale 6 minutes ago
Hiru Investors could easily compare the USA/Ukraine approach to critical minerals development, of Friday 2/28, at the White House The contrast is with the more controlled Hiru company approach, even starting last summer. The topic excites interest--Hiru cautioning against bogus "Informational" acc
HIRU

Your Recent History

AMEX
BIV
Vanguard Intermediate Term
LSE
0A4W
Acadia Pharmaceuticals
AQSE
ORA
Ora Technology
BITMOT
3045307
Eu Mfa Ukr Next Gen Fx 2...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads